By-Health Overview
- Year Founded
-
1995
- Status
-
Public
- Employees
-
2,867
- Stock Symbol
-
300146
- Investments
-
10
- Share Price
-
$1.51
- (As of Thursday Closing)
By-Health General Information
Description
By-health Co Ltd researches, develops, produces and sells nutritional supplements, functional health food, and natural dietary supplement products to help people improve their health and quality of life.
Contact Information
Website
www.by-health.comCorporate Office
- Number 19 Xinghan Road
- Sanzao Science and Technology Industrial Park, Jinwan District
- Zhuhai, Guangdong
- China
Corporate Office
- Number 19 Xinghan Road
- Sanzao Science and Technology Industrial Park, Jinwan District
- Zhuhai, Guangdong
- China
By-Health Stock Performance
As of 12-Nov-2026, By-Health’s stock price is $1.51. Its current market cap is $2.55B with 1.69B shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.51 | $1.52 | $1.30 - $1.84 | $2.55B | 1.69B | 11.7M | $0.06 |
By-Health Financials Summary
As of 30-Sep-2026, By-Health has a trailing 12-month revenue of $964M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,746,176 | 2,263,262 | 2,458,765 | 3,715,954 |
| Revenue | 964,492 | 871,255 | 953,025 | 1,329,608 |
| EBITDA | 124,523 | 176,712 | 155,692 | 336,704 |
| Net Income | 99,754 | 108,763 | 90,981 | 246,832 |
| Total Assets | 2,042,722 | 1,998,095 | 1,956,104 | 2,129,901 |
| Total Debt | 176,600 | 147,547 | 211,422 | 24,570 |
By-Health Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
By-Health Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
By-Health Patents
By-Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025205103-A1 | Postbiotic and use thereof in regulation of lipid metabolism | Pending | 21-Dec-2023 | ||
| WO-2025131132-A1 | Postbiotic and use thereof in regulation of lipid metabolism | Inactive | 21-Dec-2023 | ||
| WO-2025016307-A1 | Health homeostasis model, elastic homeostasis model, and usage method therefor | Inactive | 14-Jul-2023 | ||
| WO-2024260450-A1 | Use of water-soluble tomato concentrate in preparation of composition for treating cerebral ischemia-reperfusion injury | Inactive | 21-Jun-2023 | ||
| WO-2022166839-A1 | Use of ginkgo leaf extract in preparation of drug for targeting senescent cells, inhibiting tumors or prolonging lifetime | Inactive | 05-Feb-2021 | A61K36/16 |
By-Health Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
By-Health Investments & Acquisitions (10)
By-Health’s most recent deal was a Early Stage VC with Yuanli Semiconductor for . The deal was made on 24-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Yuanli Semiconductor | 24-Jul-2026 | Early Stage VC | Application Specific Semiconductors | ||
| Life-Space | 31-Jan-2018 | Merger/Acquisition | Pharmaceuticals | ||
| Pentavite | 01-Jan-2018 | Merger/Acquisition | Food Products | ||
| Dayima | 22-Oct-2015 | Later Stage VC | Application Software | ||
| Find Genetech | 07-Sep-2015 | Early Stage VC | Biotechnology |
By-Health ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
34.27 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Household Products
Industry
of 104
Rank
Percentile
Personal Products
Subindustry
of 84
Rank
Percentile
By-Health Exits (3)
By-Health’s most recent exit was on 07-Sep-2015 from Find Genetech. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Find Genetech | 07-Sep-2015 | Completed |
|
||
| Blue Ocean Strategy (China) | 20-Jul-2015 | Completed |
|
||
| Youkeshu Technology | 26-Jun-2015 | Later Stage VC | Completed |
|
By-Health Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Life-Space | Melbourne, Australia | 1993 | |
| Pentavite | Sydney, Australia | 1940 |
By-Health FAQs
-
When was By-Health founded?
By-Health was founded in 1995.
-
Where is By-Health headquartered?
By-Health is headquartered in Zhuhai, China.
-
What is the size of By-Health?
By-Health has 2,867 total employees.
-
What industry is By-Health in?
By-Health’s primary industry is Food Products.
-
Is By-Health a private or public company?
By-Health is a Public company.
-
What is By-Health’s stock symbol?
The ticker symbol for By-Health is 300146.
-
What is the current stock price of By-Health?
As of 12-Nov-2026 the stock price of By-Health is $1.51.
-
What is the current market cap of By-Health?
The current market capitalization of By-Health is $2.55B.
-
What is By-Health’s current revenue?
The trailing twelve month revenue for By-Health is $964M.
-
What is By-Health’s annual earnings per share (EPS)?
By-Health’s EPS for 12 months was $0.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
